| scholarly article | Q13442814 |
| P356 | DOI | 10.1093/EMBOJ/17.1.232 |
| P8608 | Fatcat ID | release_vn7ekybzyfcj5ltynjrl352tja |
| P932 | PMC publication ID | 1170374 |
| P698 | PubMed publication ID | 9427757 |
| P5875 | ResearchGate publication ID | 13802180 |
| P50 | author | David M. Heery | Q42434388 |
| P2093 | author name string | Parker MG | |
| Kalkhoven E | |||
| Valentine JE | |||
| P2860 | cites work | A direct repeat in the cellular retinol-binding protein type II gene confers differential regulation by RXR and RAR | Q24306431 |
| Adenovirus E1A functions as a cofactor for retinoic acid receptor beta (RAR beta) through direct interaction with RAR beta | Q24311404 | ||
| Cloning and characterization of a specific coactivator, ARA70, for the androgen receptor in human prostate cells | Q24314557 | ||
| Interaction of thyroid-hormone receptor with a conserved transcriptional mediator | Q24314697 | ||
| RAC3, a steroid/nuclear receptor-associated coactivator that is related to SRC-1 and TIF2 | Q24319818 | ||
| Human TAFII30 is present in a distinct TFIID complex and is required for transcriptional activation by the estrogen receptor | Q24321811 | ||
| A thyroid hormone receptor coactivator negatively regulated by the retinoblastoma protein | Q24322646 | ||
| Nuclear factor RIP140 modulates transcriptional activation by the estrogen receptor | Q24323091 | ||
| Nuclear receptor coactivator ACTR is a novel histone acetyltransferase and forms a multimeric activation complex with P/CAF and CBP/p300 | Q24324556 | ||
| A p300/CBP-associated factor that competes with the adenoviral oncoprotein E1A | Q24336667 | ||
| Differential ligand-dependent interactions between the AF-2 activating domain of nuclear receptors and the putative transcriptional intermediary factors mSUG1 and TIF1 | Q24563324 | ||
| GRIP1, a transcriptional coactivator for the AF-2 transactivation domain of steroid, thyroid, retinoid, and vitamin D receptors | Q24646387 | ||
| RIP-140 interacts with multiple nuclear receptors by means of two distinct sites | Q24648012 | ||
| Single-Step Method of RNA Isolation by Acid Guanidinium Thiocyanate–Phenol–Chloroform Extraction | Q25938986 | ||
| Characterization and colocalization of steroid binding and dimerization activities in the mouse estrogen receptor | Q38341530 | ||
| Identification of two transactivation domains in the mouse oestrogen receptor | Q38344037 | ||
| AF-2 activity and recruitment of steroid receptor coactivator 1 to the estrogen receptor depend on a lysine residue conserved in nuclear receptors | Q38347273 | ||
| Peroxisome proliferator-activated receptors and retinoic acid receptors differentially control the interactions of retinoid X receptor heterodimers with ligands, coactivators, and corepressors | Q40021918 | ||
| Characterization of the ligand-dependent transactivation domain of thyroid hormone receptor | Q40792409 | ||
| Steroid and related receptors | Q40835511 | ||
| Polarity-specific activities of retinoic acid receptors determined by a co-repressor. | Q41284148 | ||
| Characterization of ligand-dependent phosphorylation of the estrogen receptor. | Q41490731 | ||
| Identification of residues in the estrogen receptor that confer differential sensitivity to estrogen and hydroxytamoxifen | Q41574453 | ||
| Thyroid hormone regulates the oxytocin gene | Q41639160 | ||
| Functional analysis of a transactivation domain in the thyroid hormone beta receptor. | Q42493818 | ||
| A structural role for hormone in the thyroid hormone receptor. | Q46828407 | ||
| Resistance to transforming growth factor beta and activin due to reduced receptor expression in human breast tumor cell lines. | Q52206278 | ||
| A canonical structure for the ligand-binding domain of nuclear receptors | Q61818643 | ||
| A nonchromatographic assay for expression of the chloramphenicol acetyltransferase gene in eucaryotic cells | Q68733304 | ||
| Environmentally persistent alkylphenolic compounds are estrogenic | Q72019745 | ||
| Crystal structure of the RAR-gamma ligand-binding domain bound to all-trans retinoic acid | Q27729334 | ||
| Crystal structure of the ligand-binding domain of the human nuclear receptor RXR-alpha | Q27730245 | ||
| Molecular basis of agonism and antagonism in the oestrogen receptor | Q27746278 | ||
| Sequence and characterization of a coactivator for the steroid hormone receptor superfamily | Q27860465 | ||
| A CBP integrator complex mediates transcriptional activation and AP-1 inhibition by nuclear receptors | Q27860552 | ||
| The nuclear receptor superfamily: the second decade | Q27860725 | ||
| The transcriptional coactivators p300 and CBP are histone acetyltransferases | Q27860843 | ||
| A signature motif in transcriptional co-activators mediates binding to nuclear receptors | Q27860938 | ||
| The CBP co-activator is a histone acetyltransferase | Q28131758 | ||
| AIB1, a steroid receptor coactivator amplified in breast and ovarian cancer | Q28245902 | ||
| Steroid receptor coactivator-1 is a histone acetyltransferase | Q28248899 | ||
| Estrogen receptor-associated proteins: possible mediators of hormone-induced transcription | Q28254487 | ||
| Members of the steroid hormone receptor superfamily interact with TFIIB (S300-II) | Q28264307 | ||
| The major histocompatibility complex-encoded proteasome component LMP7: alternative first exons and post-translational processing | Q28267460 | ||
| The human HIV-1 Rev binding-protein hRIP/Rab (HRB) maps to chromosome 2q36 | Q28306092 | ||
| The N-terminal part of TIF1, a putative mediator of the ligand-dependent activation function (AF-2) of nuclear receptors, is fused to B-raf in the oncogenic protein T18 | Q28509358 | ||
| The transcriptional co-activator p/CIP binds CBP and mediates nuclear-receptor function | Q29547918 | ||
| Role of CBP/P300 in nuclear receptor signalling | Q29616443 | ||
| Identification of a conserved region required for hormone dependent transcriptional activation by steroid hormone receptors | Q29616455 | ||
| The human estrogen receptor has two independent nonacidic transcriptional activation functions | Q29617089 | ||
| Activation of the estrogen receptor through phosphorylation by mitogen-activated protein kinase | Q29617567 | ||
| Steroid hormone receptors: many actors in search of a plot | Q29618397 | ||
| A decade of molecular biology of retinoic acid receptors | Q29619944 | ||
| A versatile in vivo and in vitro eukaryotic expression vector for protein engineering | Q29620181 | ||
| A vector for expressing GAL4(1-147) fusions in mammalian cells | Q29620516 | ||
| Transcription activation by the adenovirus E1a protein | Q29620538 | ||
| Interaction of proteins with transcriptionally active estrogen receptors | Q35827947 | ||
| Activation of the unliganded estrogen receptor by EGF involves the MAP kinase pathway and direct phosphorylation | Q35849279 | ||
| A conserved C-terminal sequence that is deleted in v-ErbA is essential for the biological activities of c-ErbA (the thyroid hormone receptor). | Q36686878 | ||
| p300 is a component of an estrogen receptor coactivator complex | Q37258046 | ||
| The nuclear hormone receptor coactivator SRC-1 is a specific target of p300. | Q37287938 | ||
| Analysis of estrogen receptor transcriptional enhancement by a nuclear hormone receptor coactivator | Q37324395 | ||
| CREB binding protein acts synergistically with steroid receptor coactivator-1 to enhance steroid receptor-dependent transcription | Q37376082 | ||
| Activation function 2 (AF-2) of retinoic acid receptor and 9-cis retinoic acid receptor: presence of a conserved autonomous constitutive activating domain and influence of the nature of the response element on AF-2 activity | Q37638476 | ||
| Transcriptional activators differ in their responses to overexpression of TATA-box-binding protein | Q38298143 | ||
| Distinct classes of transcriptional activating domains function by different mechanisms | Q38339126 | ||
| P433 | issue | 1 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | estrogen | Q277954 |
| P304 | page(s) | 232-243 | |
| P577 | publication date | 1998-01-01 | |
| P1433 | published in | The EMBO Journal | Q1278554 |
| P1476 | title | Isoforms of steroid receptor co-activator 1 differ in their ability to potentiate transcription by the oestrogen receptor | |
| P478 | volume | 17 |
| Q64379613 | A Conserved alpha-helical motif mediates the binding of diverse nuclear proteins to the SRC1 interaction domain of CBP |
| Q35744015 | A SNP in steroid receptor coactivator-1 disrupts a GSK3β phosphorylation site and is associated with altered tamoxifen response in bone |
| Q78036257 | A comparison of transcriptional activation by ER alpha and ER beta |
| Q47663480 | A fractal analysis of analyte-estrogen receptor binding and dissociation kinetics using biosensors: environmental and biomedical effects |
| Q22254332 | A new family of nuclear receptor coregulators that integrate nuclear receptor signaling through CREB-binding protein |
| Q24291606 | A new human MR splice variant is a ligand-independent transactivator modulating corticosteroid action |
| Q37327614 | A signature motif mediating selective interactions of BCL11A with the NR2E/F subfamily of orphan nuclear receptors. |
| Q24545696 | A subfamily of RNA-binding DEAD-box proteins acts as an estrogen receptor alpha coactivator through the N-terminal activation domain (AF-1) with an RNA coactivator, SRA |
| Q22253330 | A tissue-specific coactivator of steroid receptors, identified in a functional genetic screen |
| Q28201872 | Activation function-1 domain of androgen receptor contributes to the interaction between subnuclear splicing factor compartment and nuclear receptor compartment. Identification of the p102 U5 small nuclear ribonucleoprotein particle-binding [...] |
| Q34138898 | Agonist ligands mediate the transcriptional response of nuclear receptor heterodimers through distinct stoichiometric assemblies with coactivators |
| Q34489597 | An additional region of coactivator GRIP1 required for interaction with the hormone-binding domains of a subset of nuclear receptors |
| Q24297014 | An alternative splicing variant of the selenoprotein thioredoxin reductase is a modulator of estrogen signaling |
| Q44295657 | An extended LXXLL motif sequence determines the nuclear receptor binding specificity of TRAP220. |
| Q24551037 | Analysis of the steroid receptor coactivator 1 (SRC1)-CREB binding protein interaction interface and its importance for the function of SRC1 |
| Q34125103 | Androgen receptor acetylation governs trans activation and MEKK1-induced apoptosis without affecting in vitro sumoylation and trans-repression function |
| Q44410588 | Anti-androgenic properties of Compound A, an analog of a non-steroidal plant compound |
| Q34538171 | Antisense-mediated isoform switching of steroid receptor coactivator-1 in the central nucleus of the amygdala of the mouse brain |
| Q77425825 | Association of steroid receptor coactivator AIB1 with estrogen receptor-alpha in breast cancer cells |
| Q33960598 | Biochemical analysis of distinct activation functions in p300 that enhance transcription initiation with chromatin templates |
| Q40962213 | CBP-dependent and independent enhancing activity of steroid receptor coactivator-1 in thyroid hormone receptor-mediated transactivation |
| Q96163038 | Can network pharmacology identify the anti-virus and anti- inflammatory activities of Shuanghuanglian oral liquid used in Chinese medicine for respiratory tract infection? |
| Q35138662 | Cell cycle-dependent expression of Dub3, Nanog and the p160 family of nuclear receptor coactivators (NCoAs) in mouse embryonic stem cells |
| Q37216588 | Cells in behaviourally relevant brain regions coexpress nuclear receptor coactivators and ovarian steroid receptors |
| Q77764235 | Changes in the structure of the ligand or substitutions to AF2 residues in the estrogen receptor make independent contributions to coactivator sensitivity by SRC-1 |
| Q73669906 | Cloning and functional characterization of chicken p160 coactivator family members |
| Q46623959 | Co-activators and co-repressors in the integration of transcriptional responses |
| Q53540759 | Coactivators PGC-1beta and SRC-1 interact functionally to promote the agonist activity of the selective estrogen receptor modulator tamoxifen. |
| Q33891866 | Cofactor competition between the ligand-bound oestrogen receptor and an intron 1 enhancer leads to oestrogen repression of ERBB2 expression in breast cancer |
| Q28577055 | Competition between thyroid hormone receptor-associated protein (TRAP) 220 and transcriptional intermediary factor (TIF) 2 for binding to nuclear receptors. Implications for the recruitment of TRAP and p160 coactivator complexes |
| Q31568030 | Core LXXLL motif sequences in CREB-binding protein, SRC1, and RIP140 define affinity and selectivity for steroid and retinoid receptors |
| Q34669513 | Coregulator proteins and corticosteroid action in the brain. |
| Q92449181 | Corticosteroid Action in the Brain: The Potential of Selective Receptor Modulation |
| Q57021399 | Corticosteroid Receptors in the Brain: Transcriptional Mechanisms for Specificity and Context-Dependent Effects |
| Q38471565 | Corticosteroid receptor signalling modes and stress adaptation in the brain |
| Q60628195 | Corticosteroid receptors and HPA-axis regulation |
| Q39888250 | Dax-1 and steroid receptor RNA activator (SRA) function as transcriptional coactivators for steroidogenic factor 1 in steroidogenesis |
| Q73580687 | Differential interaction of steroid hormone receptors with LXXLL motifs in SRC-1a depends on residues flanking the motif |
| Q28140877 | Differential recruitment of coactivator RIP140 by Ah and estrogen receptors. Absence of a role for LXXLL motifs |
| Q36835455 | Differential targeting of brain stress circuits with a selective glucocorticoid receptor modulator. |
| Q30815190 | Dissection of the LXXLL nuclear receptor-coactivator interaction motif using combinatorial peptide libraries: discovery of peptide antagonists of estrogen receptors alpha and beta |
| Q33957429 | Dominant activity of activation function 1 (AF-1) and differential stoichiometric requirements for AF-1 and -2 in the estrogen receptor alpha-beta heterodimeric complex |
| Q38359046 | Dual function of an amino-terminal amphipatic helix in androgen receptor-mediated transactivation through specific and nonspecific response elements |
| Q24811830 | EID3 is a novel EID family member and an inhibitor of CBP-dependent co-activation |
| Q33292447 | ERR-10: a new repressor in transcriptional signaling activation of estrogen receptor-alpha |
| Q42513929 | Effects of gender and stress on the regulation of steroid receptor coactivator-1 expression in the rat brain and pituitary. |
| Q44070466 | Effects of selective estrogen receptor modulators (SERMs) on coactivator nuclear receptor (NR) box binding to estrogen receptors. |
| Q39012681 | Engineered repressors are potent inhibitors of androgen receptor activity. |
| Q39156288 | Environmental estrogens induce transcriptionally active estrogen receptor dimers in yeast: activity potentiated by the coactivator RIP140. |
| Q28239860 | Estrogen and progesterone receptors: from molecular structures to clinical targets |
| Q31875805 | Estrogen receptor alpha and estrogen receptor-related receptor alpha1 compete for binding and coactivator |
| Q73304993 | Estrogen receptor cofactors expression in breast and endometrial human cancer cells |
| Q34371045 | Estrogen receptors: orchestrators of pleiotropic cellular responses |
| Q36697811 | Estrogens and aspects of prostate disease |
| Q36210938 | Evidence for DNA-binding domain--ligand-binding domain communications in the androgen receptor |
| Q34083450 | Factor recruitment and TIF2/GRIP1 corepressor activity at a collagenase-3 response element that mediates regulation by phorbol esters and hormones |
| Q41981657 | Fluorescence anisotropy microplate assay to investigate the interaction of full-length steroid receptor coactivator-1a with steroid receptors |
| Q40906687 | Functional analysis of R651 mutations in the putative helix 6 of rat glucocorticoid receptors |
| Q44912912 | Functional domain and motif analyses of androgen receptor coregulator ARA70 and its differential expression in prostate cancer |
| Q40727134 | Functional interaction between Brn-3a and Src-1 co-activates Brn-3a-mediated transactivation |
| Q43670950 | Functional interaction between sterol regulatory element-binding protein-1c, nuclear factor Y, and 3,5,3'-triiodothyronine nuclear receptors |
| Q28214385 | Functional interaction of STAT3 transcription factor with the coactivator NcoA/SRC1a |
| Q74069502 | Functional mutations of estrogen receptor protein: assay for detection |
| Q53396357 | Fusion estrogen receptor proteins: toward the development of receptor-based agonists and antagonists. |
| Q42292356 | Heterodimers of photoreceptor-specific nuclear receptor (PNR/NR2E3) and peroxisome proliferator-activated receptor-γ (PPARγ) are disrupted by retinal disease-associated mutations |
| Q24293751 | Human Ccr4-Not complex is a ligand-dependent repressor of nuclear receptor-mediated transcription |
| Q34717182 | Human papillomavirus E7 oncoprotein dysregulates steroid receptor coactivator 1 localization and function. |
| Q41436449 | Identification of Novel Non-secosteroidal Vitamin D Receptor Agonists with Potent Cardioprotective Effects and devoid of Hypercalcemia |
| Q54197110 | In vitro fluorescence anisotropy analysis of the interaction of full-length SRC1a with estrogen receptors alpha and beta supports an active displacement model for coregulator utilization. |
| Q33957685 | Inhibition of nuclear receptor signalling by poly(ADP-ribose) polymerase |
| Q41007539 | Interactions controlling the assembly of nuclear-receptor heterodimers and co-activators |
| Q47443085 | Isoform switching of steroid receptor co-activator-1 attenuates glucocorticoid-induced anxiogenic amygdala CRH expression. |
| Q28139007 | JAB1 interacts with both the progesterone receptor and SRC-1 |
| Q33503634 | Ligand modulated antagonism of PPARgamma by genomic and non-genomic actions of PPARdelta. |
| Q24595709 | Ligand-independent recruitment of steroid receptor coactivators to estrogen receptor by cyclin D1 |
| Q24557551 | MOZ-TIF2 inhibits transcription by nuclear receptors and p53 by impairment of CBP function |
| Q46882539 | Mechanisms of androgen receptor activation in advanced prostate cancer: differential co-activator recruitment and gene expression. |
| Q28578799 | Mechanistic principles in NR box-dependent interaction between nuclear hormone receptors and the coactivator TIF2 |
| Q24522543 | Methylation at arginine 17 of histone H3 is linked to gene activation |
| Q28084780 | Minireview: nuclear receptor coregulators of the p160 family: insights into inflammation and metabolism |
| Q40698008 | Modulation of induction properties of glucocorticoid receptor-agonist and -antagonist complexes by coactivators involves binding to receptors but is independent of ability of coactivators to augment transactivation |
| Q37480604 | Modulation of steroid action in the central and peripheral nervous systems by nuclear receptor coactivators. |
| Q39447843 | Modulation of transcriptional activation and coactivator interaction by a splicing variation in the F domain of nuclear receptor hepatocyte nuclear factor 4alpha1. |
| Q45279507 | Molecular characterization of three peroxisome proliferator-activated receptors from the sea bass (Dicentrarchus labrax). |
| Q22009427 | Molecular determinants of the estrogen receptor-coactivator interface |
| Q34007396 | Molecular mechanism of a cross-talk between oestrogen and growth factor signalling pathways |
| Q34821308 | Molecular mechanisms and cellular biology of the steroid receptor coactivator (SRC) family in steroid receptor function |
| Q24554443 | Multiple signal input and output domains of the 160-kilodalton nuclear receptor coactivator proteins |
| Q43961276 | Myb-binding protein 1a augments AhR-dependent gene expression |
| Q34013708 | Normal and cancer-related functions of the p160 steroid receptor co-activator (SRC) family |
| Q46167318 | Nuclear hormone receptor coregulator GRIP1 suppresses, whereas SRC1A and p/CIP coactivate, by domain-specific binding of MyoD. |
| Q40860785 | Nuclear receptor coactivator SRC-1 interacts with the Q-rich subdomain of the AhR and modulates its transactivation potential. |
| Q39825886 | Nuclear receptor-coregulator interaction profiling identifies TRIP3 as a novel peroxisome proliferator-activated receptor gamma cofactor |
| Q36580674 | P160/SRC/NCoA coactivators form complexes via specific interaction of their PAS-B domain with the CID/AD1 domain |
| Q38695872 | PGC1α Transcriptional Adaptor Function Governs Hepatitis B Virus Replication by Controlling HBcAg/p21 Protein-Mediated Capsid Formation. |
| Q37362740 | PPARs as new therapeutic targets for the treatment of cerebral ischemia/reperfusion injury |
| Q59351252 | Peroxisome proliferator-activated receptor γ coactivator family members competitively regulate hepatitis b virus biosynthesis |
| Q35802815 | Pharmacology of nuclear receptor-coregulator recognition. |
| Q92847908 | Phenotypic variation reveals sites of evolutionary constraint in the androgenic signaling pathway |
| Q44641074 | Piezo Electric Sensor for Endocrine-Disrupting Chemicals Using Receptor–co-factor Interaction |
| Q44565338 | Potentiation of human estrogen receptor alpha-mediated gene expression by steroid receptor coactivator-1 (SRC-1) in Saccharomyces cerevisiae |
| Q35001845 | Progesterone and Glucocorticoid Receptors Recruit Distinct Coactivator Complexes and Promote Distinct Patterns of Local Chromatin Modification |
| Q39641620 | Progesterone and estradiol effects on SRC-1 and SRC-3 expression in human astrocytoma cell lines |
| Q24302289 | Prohibitin, a protein downregulated by androgens, represses androgen receptor activity |
| Q34136185 | Proteins interacting with the mammalian estrogen receptor: proposal for an integrated model for estrogen receptor mediated regulation of transcription |
| Q24554468 | Purification and identification of p68 RNA helicase acting as a transcriptional coactivator specific for the activation function 1 of human estrogen receptor alpha |
| Q42906978 | Raised hepatic bile acid concentrations during pregnancy in mice are associated with reduced farnesoid X receptor function. |
| Q33598764 | Recurrent t(2;2) and t(2;8) translocations in rhabdomyosarcoma without the canonical PAX-FOXO1 fuse PAX3 to members of the nuclear receptor transcriptional coactivator family |
| Q24554355 | Redox-regulated recruitment of the transcriptional coactivators CREB-binding protein and SRC-1 to hypoxia-inducible factor 1alpha |
| Q24290687 | Relationships of the antiproliferative proteins BTG1 and BTG2 with CAF1, the human homolog of a component of the yeast CCR4 transcriptional complex: involvement in estrogen receptor alpha signaling pathway |
| Q24298419 | Repression of androgen receptor activity by HEYL, a third member of the Hairy/Enhancer-of-split-related family of Notch effectors |
| Q27025212 | Role of Nuclear Receptors in Central Nervous System Development and Associated Diseases |
| Q38306939 | Role of accessory factors and steroid receptor coactivator 1 in the regulation of phosphoenolpyruvate carboxykinase gene transcription by glucocorticoids |
| Q39296019 | Role of the HSP90-associated cochaperone p23 in enhancing activity of the androgen receptor and significance for prostate cancer |
| Q35641879 | STAMP, a novel predicted factor assisting TIF2 actions in glucocorticoid receptor-mediated induction and repression |
| Q24291743 | Selective coactivation of estrogen-dependent transcription by CITED1 CBP/p300-binding protein |
| Q39610821 | Selective interaction of vitamin D receptor with transcriptional coactivators by a vitamin D analog |
| Q48422052 | Sex differences in the distribution of the steroid receptor coactivator SRC-1 in the song control nuclei of male and female canaries |
| Q24562820 | Single-chain estrogen receptors (ERs) reveal that the ERalpha/beta heterodimer emulates functions of the ERalpha dimer in genomic estrogen signaling pathways |
| Q33964709 | Specific structural motifs determine TRAP220 interactions with nuclear hormone receptors |
| Q24812719 | SpectralNET--an application for spectral graph analysis and visualization |
| Q37194706 | Steroid receptor coactivator-1 is necessary for regulation of corticotropin-releasing hormone by chronic stress and glucocorticoids. |
| Q33834146 | Steroid/nuclear receptor coactivators |
| Q27663940 | Structural basis of the histidine-mediated vitamin D receptor agonistic and antagonistic mechanisms of (23S)-25-dehydro-1α-hydroxyvitamin D3-26,23-lactone |
| Q44044539 | Structural regions of ERalpha critical for synergistic transcriptional responses contain co-factor interacting surfaces |
| Q30779792 | Structure and chromosomal locations of mouse steroid receptor coactivator gene family |
| Q27765991 | Structure and specificity of nuclear receptor-coactivator interactions |
| Q27652846 | Structure of the ligand-binding domain of rat VDR in complex with the nonsecosteroidal vitamin D3analogue YR301 |
| Q28343990 | Structure-function relationships of the raloxifene-estrogen receptor-alpha complex for regulating transforming growth factor-alpha expression in breast cancer cells |
| Q40641807 | Subcellular localization and mechanisms of nucleocytoplasmic trafficking of steroid receptor coactivator-1. |
| Q24817047 | T:G mismatch-specific thymine-DNA glycosylase (TDG) as a coregulator of transcription interacts with SRC1 family members through a novel tyrosine repeat motif |
| Q28188710 | T:G mismatch-specific thymine-DNA glycosylase potentiates transcription of estrogen-regulated genes through direct interaction with estrogen receptor alpha |
| Q24534273 | Targeting of SWI/SNF chromatin remodelling complexes to estrogen-responsive genes |
| Q24554379 | The AF1 and AF2 domains of the androgen receptor interact with distinct regions of SRC1 |
| Q33860695 | The SRC family of nuclear receptor coactivators |
| Q24298845 | The affinity and activity of the multiple hormone response element in the proximal promoter of the human oxytocin gene |
| Q38321491 | The androgen receptor amino-terminal domain plays a key role in p160 coactivator-stimulated gene transcription |
| Q24320338 | The coactivator TIF2 contains three nuclear receptor-binding motifs and mediates transactivation through CBP binding-dependent and -independent pathways |
| Q44529187 | The coactivator p/CIP/SRC-3 facilitates retinoic acid receptor signaling via recruitment of GCN5. |
| Q30164406 | The focal adhesion protein vinexin alpha regulates the phosphorylation and activity of estrogen receptor alpha |
| Q41772682 | The mouse and human Ah receptor differ in recognition of LXXLL motifs |
| Q42546530 | The multiple endocrine neoplasia type 1 (MEN1) tumor suppressor regulates peroxisome proliferator-activated receptor gamma-dependent adipocyte differentiation. |
| Q39961304 | The natural compound atraric acid is an antagonist of the human androgen receptor inhibiting cellular invasiveness and prostate cancer cell growth |
| Q34180330 | The nuclear hormone receptor coactivator NRC is a pleiotropic modulator affecting growth, development, apoptosis, reproduction, and wound repair |
| Q47926627 | The nuclear receptor ligand-binding domain: structure and function |
| Q38330089 | The orphan nuclear receptor SHP inhibits agonist-dependent transcriptional activity of estrogen receptors ERalpha and ERbeta |
| Q24554322 | The orphan nuclear receptor SHP utilizes conserved LXXLL-related motifs for interactions with ligand-activated estrogen receptors |
| Q35671179 | The role of coactivators and corepressors in the biology and mechanism of action of steroid hormone receptors |
| Q28509946 | The steroid receptor coactivator SRC-3 (p/CIP/RAC3/AIB1/ACTR/TRAM-1) is required for normal growth, puberty, female reproductive function, and mammary gland development |
| Q36898469 | Therapeutic potential of selective modulators of nuclear receptor action |
| Q36841870 | Thermodynamic characterization of the interaction between CAR-RXR and SRC-1 peptide by isothermal titration calorimetry |
| Q47682465 | Thyroid hormone response elements differentially modulate the interactions of thyroid hormone receptors with two receptor binding domains in the steroid receptor coactivator-1. |
| Q24336164 | Two distinct nuclear receptor interaction domains in NSD1, a novel SET protein that exhibits characteristics of both corepressors and coactivators |
| Q33968602 | Use of suppressor mutants to probe the function of estrogen receptor-p160 coactivator interactions |
| Q37288077 | Who's in charge? Nuclear receptor coactivator and corepressor function in brain and behavior |
| Q28609750 | p300 interacts with the N- and C-terminal part of PPARgamma2 in a ligand-independent and -dependent manner, respectively |
Search more.